Patricia A. Bradford - 09 Aug 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
09 Aug 2022
Net transactions value
$0
Form type
4
Filing time
26 Sep 2022, 19:00:13 UTC
Previous filing
29 Apr 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Award $0 +20,000 $0.000000 20,000 09 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.